Molecular Therapy — Methods & Clinical Development
ISSN 2329-0501 · Cell Press · United States · active 1970–2025
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Molecular Therapy — Methods & Clinical Development a predatory journal?
Our screening does not flag Molecular Therapy — Methods & Clinical Development. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, PubMed, which is a positive signal.
Is Molecular Therapy — Methods & Clinical Development indexed in Scopus or Web of Science?
Per our venue index, Molecular Therapy — Methods & Clinical Development appears in: DOAJ, Scopus, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Molecular Therapy — Methods & Clinical Development's impact?
Papers in Molecular Therapy — Methods & Clinical Development are cited about 4.2 times each within two years of publication, and Scimago places it in Q1, with an h-index of 89. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Molecular Therapy — Methods & Clinical Development open access?
Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.